Maybe It's Not Over

Google AI reports the following:

"Studies have shown that when the FDA advisory committee votes against a drug approval, the FDA still sometimes chooses to approve it, indicating a tendency to favor approval in cases of discordance."

"According to research, when there is a disagreement between the FDA and its advisory committees, the FDA is generally more likely to lean towards approving a drug than its advisors would, meaning the FDA may be more willing to approve a drug even if the advisory committee recommends against it."

"Some factors that might contribute to the FDA leaning towards approval in these cases include pressure from the pharmaceutical industry, the need to provide access to potentially beneficial drugs, or a different interpretation of the data."

I might hold until 12.20.2024.